(Q40940050)

25 September 2017

1 reference

title

Current knowledge and future prospects for the use of HIV protease inhibitors (English)

1 reference

25 September 2017

G Moyle

1

1 reference

PubMed ID

8861542

25 September 2017

B Gazzard

series ordinal

2

1 reference

25 September 2017

1 May 1996

1 reference

25 September 2017

1 reference

25 September 2017

51

1 reference

25 September 2017

701-712

1 reference

25 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651050-00001

25 September 2017

0 references

cites work

Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine

1 reference

12 December 2020

HIV protease inhibitors.

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?

1 reference

12 December 2020

Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 December 2020

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Influence of emergence of viral resistance on HIV treatment choice

1 reference

12 December 2020

Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials

1 reference

12 December 2020

Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy

1 reference

12 December 2020

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

12 December 2020

HIV treatment choice based on resistance patterns.

1 reference

12 December 2020

HIV therapy advances. Update on a proteinase inhibitor

1 reference

12 December 2020

In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol

1 reference

12 December 2020

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

1 reference

12 December 2020

Safety and activity of saquinavir in HIV infection

1 reference

12 December 2020

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

1 reference

12 December 2020

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

12 December 2020

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

12 December 2020

Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum alpha 1 acid glycoprotein.

1 reference

12 December 2020

The pc12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs

1 reference

12 December 2020

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

1 reference

12 December 2020

Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro

1 reference

12 December 2020

Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells

1 reference

12 December 2020

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

12 December 2020

Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication

1 reference

12 December 2020

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

12 December 2020

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group

1 reference

12 December 2020

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity

1 reference

12 December 2020

10.2165/00003495-199651050-00001

Identifiers

DOI

1 reference

PubMed ID

8861542

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8861542